SSPL Securities Private Limited

Saturday 16 Aug, 2025 03:48 PM

Lemon Tree Hotels' arm wins DDA bid to develop 5-star Aurika hotel in Delhi's Nehru Place EMS bags Rs 104-cr water supply project from UP Jal Nigam Vipul Organics Q1 PAT climbs 12% YoY to Rs 1 cr Globe Civil Projects secures Rs 222.19-cr order from Haryana Cricket Association Brahmaputra Infra Q1 PAT skyrockets 122% YoY to Rs 15 cr Jyoti Structures Q1 PAT jumps 119% YoY to Rs 11 cr Ola Electric unveils 'India Inside' vision, new EVs, ferrite motor and MoveOS 6 at Sankalp 2025 Alembic Pharma secures USFDA nod for generic acne cream Vodafone Idea Q1 revenue inches higher, losses widen Vishal Mega Mart posts over 37% YoY rise in Q1 PAT; store count rises to 717 Borosil Q1 PAT climbs 87% YoY to Rs 17 cr IRB Infra gains after Q1 PAT climbs 45% YoY to Rs 202 cr Ashok Leyland gains after Q1 PAT rises 13% YoY to Rs 594 cr Nava drops after Q1 PAT slides 10.5% YoY Surya Roshni Ltd leads losers in 'A' group

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Alembic Pharma secures USFDA nod for generic acne cream

16-Aug-25 10:00 Hrs IST

The product is therapeutically equivalent to Bausch Health's Retin-A Cream, 0.025%, and is indicated for the topical treatment of acne vulgaris. The cream has an estimated market size of $94 million for the 12 months ended June 2025, according to IQVIA.

With this nod, Alembic's cumulative ANDA approvals now stand at 224, including 202 final and 22 tentative approvals.

Alembic Pharmaceuticals is a vertically integrated research-driven company that manufactures and markets generic medicines globally.

The company's consolidated net profit jumped 14.18% to Rs 156.63 crore while revenue from operations grew 9.54% to Rs 1,710.72 crore in Q1 June 2025 over Q1 June 2024.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 43490656

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)